The healthcare and life science markets are in a period of dramatic change.
Despite this change, successful private equity funds can still execute deals and achieve capital growth by implementing the right strategies in the right markets. Join us at

Continue Reading McGuireWoods Announces 9th Annual Healthcare & Life Sciences Private Equity & Finance Conference

It is a rare healthcare company that has no regulatory risk exposure in at least a few material areas.  As sellers of healthcare companies prepare them for sale, they will need to navigate first the letter of intent (LOI) stage

Continue Reading Four Key Strategies For Navigating Regulatory Issues at the Letter of Intent Stage When Selling a Healthcare Company

Current Trends in Healthcare M&A

Tuesday, September 20, 2011

7:30 – 10 a.m.
The Ritz-Carlton
100 Carondelet Plaza
St. Louis, Missouri

McGuireWoods LLP, Clayton Capital Partners, KPMG, Lockton and the St. Louis RCGA invite you to join us for an

Continue Reading McGuireWoods to Co-Host Current Trends in Healthcare M&A Breakfast Seminar in St. Louis

Selling a healthcare company is a daunting task that requires significant foresight, planning and expertise in addition to the tremendous amount of time required to consummate a deal. For a first time seller, the process is especially intimidating as the

Continue Reading Preparing Your Healthcare Company for Sale: An Interview with Bill Siren of AlixPartners (Part I)

            A few weeks ago, McGuireWoods hosted our 8th Annual Healthcare & Life Sciences Private Equity & Finance Conference along with co-sponsor McGladrey.  The Hon. Bill Frist gave the keynote address.  It was a real treat to

Continue Reading Value-Based Healthcare Solutions: A Prescription for Investors in an Era of Healthcare Reform

In recent years there has been growing public awareness of end of life decisions and the importance of documenting advance healthcare decisions. In fact, April 16th is National Healthcare Decisions Day, a nationwide educational event founded by McGuireWoods partner

Continue Reading Advance Directives: Implications for Patients, Healthcare Providers and Emerging Healthcare IT Businesses